Conduent Leverages GenAI to Transform Reportable Event Detection and Establish New FDA Compliance Standards
Written by Emily J. Thompson, Senior Investment Analyst
Source: Newsfilter
Updated: Nov 05 20250mins
New GenAI Solution Launch: Conduent has introduced a GenAI-powered reportable event detection solution designed to enhance the identification of events for Pharma and Life Sciences companies, ensuring compliance with FDA regulations.
Improved Efficiency and Compliance: The solution automates the review of nearly 100% of customer interactions across various channels, improving the speed, accuracy, and consistency of identifying reportable events, thus minimizing the risk of penalties.
Real-World Applications: Examples of reportable events include patient reports of adverse reactions, caregiver complaints about product issues, and customer inquiries regarding dosage instructions, all of which can now be efficiently captured and classified.
Integration with Microsoft Azure OpenAI: This new tool leverages Microsoft Azure OpenAI to combine AI capabilities with compliance expertise, ultimately helping clients save time and costs while enhancing patient safety and product quality.
CNDT.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on CNDT
Wall Street analysts forecast CNDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNDT is 7.00 USD with a low forecast of 7.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.050
Low
7.00
Averages
7.00
High
7.00
Current: 2.050
Low
7.00
Averages
7.00
High
7.00
No Data
About CNDT
Conduent Incorporated is a global technology-led business process solutions and services company. The Company’s Commercial segment provides business process services that span its clients’ business processes end-to-end from the front-office to the back-office for a variety of commercial industries. Its technology-led solutions and services include Customer Experience Management (CXM), Business Operations Solutions (BOS), Healthcare Claims and Administration Solutions and Human Capital Solutions (HCS). Its Government segment provides government-centric services and solutions to U.S. federal, state, local and foreign governments for public assistance, healthcare programs and administration, transaction processing, payment services and case management. Its Transportation segment provides systems, support and revenue-generating solutions to government transportation agency clients. It delivers mission-critical tolling, transit and digital payment solutions that streamline operations.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
What factors contributed to Conduent's 5% year-over-year revenue decline?
How did operational improvements impact Conduent's adjusted EBITDA in Q3 2025?
Will Conduent's revised revenue guidance affect its stock performance in Q4 2025?
How might Conduent's liquidity position influence its ability to reduce debt?